Canaccord raises Atai Life Sciences stock price target to $17 on MDD plans

Markets Investing.com By Investing.com 07 Jul 2026 11:48 1 min read

Canaccord raises Atai Life Sciences stock price target to $17 on MDD plans

Canaccord raises Atai Life Sciences stock price target to $17 on MDD plans

Canaccord raises Atai Life Sciences stock price target to $17 on MDD plans

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.